Ambee Pharmaceuticals PLC (DSE: AMBEEPHA)
Bangladesh
· Delayed Price · Currency is BDT 721.30
-24.80 (-3.32%)
At close: Nov 14, 2024
Ambee Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Net Income | 10.68 | 9.09 | 8.06 | -13.01 | 3.64 | 3.37 | Upgrade
|
| Depreciation & Amortization | 8.79 | 7.54 | 6.05 | 6.92 | 7.93 | 7.86 | Upgrade
|
| Other Operating Activities | -31.69 | -37.09 | -0.09 | -0.32 | -0.3 | 0.31 | Upgrade
|
| Change in Accounts Receivable | -35.9 | -23.43 | -20.28 | -23.08 | -4.09 | 7.5 | Upgrade
|
| Change in Inventory | -29.64 | -18.36 | -50 | 31.37 | -15.73 | 9.42 | Upgrade
|
| Change in Accounts Payable | -2.07 | -1.57 | -0.67 | -2.84 | -1.02 | 1.05 | Upgrade
|
| Change in Income Taxes | 20.54 | 22.13 | -2.75 | 1.05 | 1.61 | -1.74 | Upgrade
|
| Change in Other Net Operating Assets | -6.14 | 6.46 | -13.51 | -5.54 | -4 | 11.64 | Upgrade
|
| Operating Cash Flow | -65.43 | -35.23 | -73.18 | -5.45 | -11.97 | 39.4 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | 111.54% | Upgrade
|
| Capital Expenditures | -2.01 | -0.11 | -1.53 | - | -0.71 | -0.37 | Upgrade
|
| Other Investing Activities | - | - | - | - | -3.26 | - | Upgrade
|
| Investing Cash Flow | -2.01 | -0.11 | -1.53 | - | -3.97 | -0.37 | Upgrade
|
| Short-Term Debt Issued | - | 101.48 | 132.69 | 10.62 | 25.51 | - | Upgrade
|
| Total Debt Issued | 90.14 | 101.48 | 132.69 | 10.62 | 25.51 | - | Upgrade
|
| Short-Term Debt Repaid | - | -52.54 | -51.56 | - | - | -26.81 | Upgrade
|
| Long-Term Debt Repaid | - | -0.96 | -3.09 | -0.87 | -1.07 | -8.65 | Upgrade
|
| Total Debt Repaid | -0.15 | -53.5 | -54.65 | -0.87 | -1.07 | -35.47 | Upgrade
|
| Net Debt Issued (Repaid) | 89.99 | 47.98 | 78.04 | 9.76 | 24.45 | -35.47 | Upgrade
|
| Common Dividends Paid | -3.18 | -1 | -1.5 | -0.33 | -2.95 | -10.66 | Upgrade
|
| Other Financing Activities | -0.65 | - | - | - | - | 0 | Upgrade
|
| Financing Cash Flow | 86.16 | 46.98 | 76.54 | 9.43 | 21.49 | -46.13 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | 0 | - | - | - | - | Upgrade
|
| Net Cash Flow | 18.72 | 11.64 | 1.83 | 3.98 | 5.55 | -7.09 | Upgrade
|
| Free Cash Flow | -67.44 | -35.34 | -74.71 | -5.45 | -12.68 | 39.03 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 203.65% | Upgrade
|
| Free Cash Flow Margin | -32.86% | -17.84% | -41.28% | -5.51% | -4.45% | 12.15% | Upgrade
|
| Free Cash Flow Per Share | -28.10 | -14.72 | -31.13 | -2.27 | -5.28 | 16.26 | Upgrade
|
| Cash Interest Paid | 2.06 | 3.69 | 5.77 | 5.82 | 7.65 | 7.92 | Upgrade
|
| Cash Income Tax Paid | 15.01 | 15.47 | 5.85 | -31.12 | 3.24 | 5.66 | Upgrade
|
| Levered Free Cash Flow | -50.9 | 1.12 | -104.8 | -2.47 | 6.33 | 28.01 | Upgrade
|
| Unlevered Free Cash Flow | -50.36 | 2.68 | -101.91 | 0.65 | 10.43 | 32.37 | Upgrade
|
| Change in Net Working Capital | 65.38 | 12.98 | 115.72 | 1.72 | 3.98 | -12.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.